Two Investors to Own Stake in Fujian Cosunter Pharmaceutical's Unit for 191 Million Yuan

MT Newswires Live

09/03

Two investors agreed to acquire a stake in Fujian Cosunter Pharmaceutical's (SHE:300436) unit, Fujian Cosunter Zhonglin Biotechnology, for a total consideration of 191.4 million yuan, according to a Tuesday filing on the Shenzhen bourse.

The Chinese pharmaceutical company's shares slipped less than 1% at the close of Wednesday's trade.

Fuzhou Aotai Phase V Investment Partnership (Limited Partnership) and Fuzhou Aotai Phase VI Investment Partnership (Limited Partnership) will subscribe to Cosunter Zhonglin Biotech's new registered capital worth 29.7 million yuan.

After the transaction, Cosunter's stake in Cosunter Zhonglin Biotech will decline to 75.3% from 81.1%.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2564636403"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2564636403\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2564636403?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-03 16:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2564636403","market":"us","top_or_hot":-1,"title":"Two Investors to Own Stake in Fujian Cosunter Pharmaceutical's Unit for 191 Million Yuan","media":"MT Newswires Live","content":"<html><body><p> Two investors agreed to acquire a stake in <a href=\"https://laohu8.com/S/300436\">Fujian Cosunter</a> Pharmaceutical's (SHE:300436) unit, Fujian Cosunter Zhonglin Biotechnology, for a total consideration of 191.4 million yuan, according to a Tuesday filing on the Shenzhen bourse.</p><p>The Chinese pharmaceutical company's shares slipped less than 1% at the close of Wednesday's trade.</p><p>Fuzhou Aotai Phase V Investment Partnership (Limited Partnership) and Fuzhou Aotai Phase VI Investment Partnership (Limited Partnership) will subscribe to Cosunter Zhonglin Biotech's new registered capital worth 29.7 million yuan.</p><p>After the transaction, Cosunter's stake in Cosunter Zhonglin Biotech will decline to 75.3% from 81.1%.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Two Investors to Own Stake in Fujian Cosunter Pharmaceutical's Unit for 191 Million Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTwo Investors to Own Stake in Fujian Cosunter Pharmaceutical's Unit for 191 Million Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-03 16:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Two investors agreed to acquire a stake in <a href=\"https://laohu8.com/S/300436\">Fujian Cosunter</a> Pharmaceutical's (SHE:300436) unit, Fujian Cosunter Zhonglin Biotechnology, for a total consideration of 191.4 million yuan, according to a Tuesday filing on the Shenzhen bourse.</p><p>The Chinese pharmaceutical company's shares slipped less than 1% at the close of Wednesday's trade.</p><p>Fuzhou Aotai Phase V Investment Partnership (Limited Partnership) and Fuzhou Aotai Phase VI Investment Partnership (Limited Partnership) will subscribe to Cosunter Zhonglin Biotech's new registered capital worth 29.7 million yuan.</p><p>After the transaction, Cosunter's stake in Cosunter Zhonglin Biotech will decline to 75.3% from 81.1%.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2564636403","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2564636403","pubTimestamp":1756886887,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Two investors agreed to acquire a stake in Fujian Cosunter Pharmaceutical's  unit, Fujian Cosunter Zhonglin Biotechnology, for a total consideration of 191.4 million yuan, according to a Tuesday filing on the Shenzhen bourse.The Chinese pharmaceutical company's shares slipped less than 1% at the close of Wednesday's trade.Fuzhou Aotai Phase V Investment Partnership  and Fuzhou Aotai Phase VI Investment Partnership  will subscribe to Cosunter Zhonglin Biotech's new registered capital worth 29.7 million yuan.After the transaction, Cosunter's stake in Cosunter Zhonglin Biotech will decline to 75.3% from 81.1%.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300436":"广生堂","BK0239":"医药制造","BK4211":"区域性银行","ISBC":"投资者银行"},"translate_title":"两名投资者以1.91亿元入股福建科森特药业子公司","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300436":0.9,"ISBC":1},"content_text":"Two investors agreed to acquire a stake in Fujian Cosunter Pharmaceutical's (SHE:300436) unit, Fujian Cosunter Zhonglin Biotechnology, for a total consideration of 191.4 million yuan, according to a Tuesday filing on the Shenzhen bourse.The Chinese pharmaceutical company's shares slipped less than 1% at the close of Wednesday's trade.Fuzhou Aotai Phase V Investment Partnership (Limited Partnership) and Fuzhou Aotai Phase VI Investment Partnership (Limited Partnership) will subscribe to Cosunter Zhonglin Biotech's new registered capital worth 29.7 million yuan.After the transaction, Cosunter's stake in Cosunter Zhonglin Biotech will decline to 75.3% from 81.1%.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}